Hsa_circ_0072732 enhances sunitinib resistance of renal cell carcinoma by inhibiting ferroptosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Hsa_circ_0072732 enhances sunitinib resistance of renal cell carcinoma by inhibiting ferroptosis ; volume:15 ; number:1 ; day:23 ; month:11 ; year:2024 ; pages:1-13 ; date:12.2024
Discover oncology ; 15, Heft 1 (23.11.2024), 1-13, 12.2024
- Urheber
-
Tian, Xiaorui
Liu, Jun
Yi, Cheng
You, Xiangyun
Yuan, Chunli
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12672-024-01580-2
- URN
-
urn:nbn:de:101:1-2502092106526.161795181196
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tian, Xiaorui
- Liu, Jun
- Yi, Cheng
- You, Xiangyun
- Yuan, Chunli
- SpringerLink (Online service)
Ähnliche Objekte (12)
Hsa_circ_0000497 and hsa_circ_0000918 contributed to peritoneal metastasis of ovarian cancer via ascites
A novel circRNA, hsa_circ_0069382, regulates gastric cancer progression
Salivary Circular RNAs Hsa_Circ_0001874 and Hsa_Circ_0001971 as Novel Biomarkers for the Diagnosis of Oral Squamous Cell Carcinoma
Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3
Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
Identification of Plasma hsa_circ_0001230 and hsa_circ_0023879 as Potential Novel Biomarkers for Focal Segmental Glomerulosclerosis and circRNA-miRNA-mRNA Network Analysis
Hsa_circ_0006010 and hsa_circ_0002903 in peripheral blood serve as novel diagnostic, surveillance and prognostic biomarkers for disease progression in chronic myeloid leukemia
Hsa_Circ_0001275: A Potential Novel Diagnostic Biomarker for Postmenopausal Osteoporosis
Retraction Note: Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer
Hsa_circ_0046264 up-regulated BRCA2 to suppress lung cancer through targeting hsa-miR-1245
CircRNA hsa_circ_0002577 accelerates endometrial cancer progression through activating IGF1R/PI3K/Akt pathway
Hsa_circ_0000497 and hsa_circ_0000918 contributed to peritoneal metastasis of ovarian cancer via ascites
A novel circRNA, hsa_circ_0069382, regulates gastric cancer progression
Salivary Circular RNAs Hsa_Circ_0001874 and Hsa_Circ_0001971 as Novel Biomarkers for the Diagnosis of Oral Squamous Cell Carcinoma
Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3
Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
Identification of Plasma hsa_circ_0001230 and hsa_circ_0023879 as Potential Novel Biomarkers for Focal Segmental Glomerulosclerosis and circRNA-miRNA-mRNA Network Analysis
Hsa_circ_0006010 and hsa_circ_0002903 in peripheral blood serve as novel diagnostic, surveillance and prognostic biomarkers for disease progression in chronic myeloid leukemia
Hsa_Circ_0001275: A Potential Novel Diagnostic Biomarker for Postmenopausal Osteoporosis
Retraction Note: Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer
Hsa_circ_0046264 up-regulated BRCA2 to suppress lung cancer through targeting hsa-miR-1245
CircRNA hsa_circ_0002577 accelerates endometrial cancer progression through activating IGF1R/PI3K/Akt pathway
Hsa_circ_0000497 and hsa_circ_0000918 contributed to peritoneal metastasis of ovarian cancer via ascites
A novel circRNA, hsa_circ_0069382, regulates gastric cancer progression
Salivary Circular RNAs Hsa_Circ_0001874 and Hsa_Circ_0001971 as Novel Biomarkers for the Diagnosis of Oral Squamous Cell Carcinoma
Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3
Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
Identification of Plasma hsa_circ_0001230 and hsa_circ_0023879 as Potential Novel Biomarkers for Focal Segmental Glomerulosclerosis and circRNA-miRNA-mRNA Network Analysis
Hsa_circ_0006010 and hsa_circ_0002903 in peripheral blood serve as novel diagnostic, surveillance and prognostic biomarkers for disease progression in chronic myeloid leukemia
Hsa_Circ_0001275: A Potential Novel Diagnostic Biomarker for Postmenopausal Osteoporosis
Retraction Note: Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer
Hsa_circ_0046264 up-regulated BRCA2 to suppress lung cancer through targeting hsa-miR-1245